首页> Eye (London, England)> Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.

Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases.

导出 OA

翻译打印收藏纠错

第一作者： Jean-François,Korobelnik

第一单位： CHU Bordeaux, Service d'ophtalmologie, Bordeaux, France.;University of Bordeaux, INSERM, BPH, UMR1219, Bordeaux, France.

作者： Jean-François,Korobelnik ^[1] ; Paolo,Lanzetta ^[2] ; Charles C,Wykoff ^[3] ; Tien Y,Wong ^[4] ; Xin,Zhang ^[5] ; Peter,Morgan-Warren ^[5] ; Scott,Fitzpatrick ^[6] ; Sergio,Leal ^[5] ; Lynne,Brunck ^[5] ; Zoran,Hasanbasic ^[5] ; Karen W,Chu ^[7] ; Kimberly,Reed ^[7] ; Sobha,Sivaprasad ^[8]

作者单位： CHU Bordeaux, Service d'ophtalmologie, Bordeaux, France.;University of Bordeaux, INSERM, BPH, UMR1219, Bordeaux, France. ^[1] Department of Medicine - Ophthalmology, University of Udine, and Istituto Europeo di Microchirurgia Oculare - IEMO, Udine, Italy. ^[2] Retina Consultants of Texas, Retina Consultants of America, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA. ^[3] Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.;Tsinghua Medicine, Tsinghua University, Beijing, China. ^[4] Bayer Consumer Care AG, Basel, Switzerland. ^[5] Bayer Inc., Mississauga, Ontario, Canada. ^[6] Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA. ^[7] NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK. senswathi@aol.com. ^[8]

DOI 10.1038/s41433-024-03312-w

PMID 39217260

发布时间 2024-11-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交